IRIS
ZAPPAVIGNA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.564
EU - Europa 2.386
AS - Asia 477
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
AF - Africa 1
Totale 5.442
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.555
IE - Irlanda 799
IT - Italia 558
GB - Regno Unito 229
UA - Ucraina 225
DE - Germania 172
SG - Singapore 162
CN - Cina 137
FR - Francia 105
SE - Svezia 86
FI - Finlandia 79
GR - Grecia 69
VN - Vietnam 54
TR - Turchia 50
BE - Belgio 20
KR - Corea 19
NL - Olanda 12
PK - Pakistan 10
CA - Canada 9
IN - India 9
JP - Giappone 9
IR - Iran 7
PL - Polonia 7
BR - Brasile 6
CZ - Repubblica Ceca 5
ES - Italia 5
AU - Australia 4
EU - Europa 4
HK - Hong Kong 4
PH - Filippine 4
RU - Federazione Russa 4
TW - Taiwan 4
ID - Indonesia 3
AT - Austria 2
CH - Svizzera 2
DK - Danimarca 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
EE - Estonia 1
IL - Israele 1
KE - Kenya 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 5.442
Salva come PNG Salva come JPEG
Città #
Dublin 799
Chandler 517
Santa Clara 432
Jacksonville 363
Singapore 99
Caserta 98
Princeton 96
Roxbury 83
New York 79
Medford 73
Naples 63
Boardman 58
Bremen 58
Ann Arbor 54
Dong Ket 54
Des Moines 35
Cambridge 33
Wilmington 33
Napoli 31
Beijing 29
Aversa 28
Woodbridge 25
Mountain View 24
Helsinki 22
San Mateo 22
Ashburn 21
Los Angeles 20
Brussels 19
Milan 19
Munich 18
Rome 12
Campodarsego 11
San Nicola la Strada 10
Seoul 10
Istanbul 9
San Felice A Cancello 9
Jinan 8
Elora 7
Houston 7
Nanjing 7
Piscataway 7
Redwood City 7
Xi'an 7
Düsseldorf 6
Guangzhou 6
Seregno 6
Tianjin 6
Amsterdam 5
Auburn Hills 5
Brno 5
Clifton 5
Lissone 5
Madrid 5
Ningbo 5
Norwalk 5
Scafati 5
Bahawalpur 4
Berlin 4
Changsha 4
Delhi 4
Frankfurt am Main 4
Lappeenranta 4
Taipei 4
Torre Annunziata 4
Bologna 3
Groningen 3
Hebei 3
Hong Kong 3
Jakarta 3
Panettieri 3
Portici 3
Quezon City 3
San Giorgio a Cremano 3
Scandiano 3
Seattle 3
Shenyang 3
Siena 3
São Paulo 3
Taiyuan 3
Washington 3
Amantea 2
Cagliari 2
Capannori 2
Chengdu 2
Chiba 2
Chicago 2
Cosenza 2
Dearborn 2
Fairfield 2
Florence 2
Frattaminore 2
Freigericht 2
Genova 2
Gragnano 2
Haikou 2
Hyderabad 2
Kunming 2
London 2
Nanchang 2
North Bergen 2
Totale 3.605
Salva come PNG Salva come JPEG
Nome #
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 106
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 104
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 93
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 92
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 91
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells 89
Effect of restriction vegan diet's on muscle mass, oxidative status, and myocytes differentiation: A pilot study 88
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 78
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 78
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 78
Mitochondria as playmakers of apoptosis, autophagy and senescence 78
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 76
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 75
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 74
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 74
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 73
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 70
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 70
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 69
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. 69
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 67
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 67
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 66
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 66
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 66
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 66
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 65
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells 65
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 65
Erlotinib: early clinical development in brain cancer. 63
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 63
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 63
Emerging pathways as individualized therapeutic target of multiple myeloma. 61
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. 60
Interleukin 18: Friend or foe in cancer. 60
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 59
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 59
Anti-inflammatory drugs as anticancer agents 59
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. 58
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 58
Drug-drug interactions based on pharmacogenetic profile between highly active antiretroviral therapy and antiblastic chemotherapy in cancer patients with HIV infection 58
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 58
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 56
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors 56
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 56
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines 56
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 56
Measurement of autophagy by flow cytometry 56
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. 55
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 53
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 53
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 52
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 52
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. 51
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 51
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 50
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. 49
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 49
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? 48
Ipilimumab for the treatment of metastatic prostate cancer 48
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 47
Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: Clinical and occupational implications 47
Peptide functionalization of silicon for detection and classification of prostatic cells 47
CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY 47
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 47
Testicular cancer from diagnosis to epigenetic factors 46
Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance 46
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides. 45
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 45
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 44
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 44
The role of micrornas in development of colitis-associated colorectal cancer 43
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 42
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 42
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. 41
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy 41
Autophagic cell death: A new frontier in cancer research 41
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 40
Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid 40
Nanotechnologies to use zoledronic acid as a potent antitumoral agent 40
Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy? 40
Long non-coding RNAs in cancer stem cells 40
In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role? 39
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 38
Hepatocarcinoma: genetic and epigenetic features 38
Non-coding RNAs as a new dawn in tumor diagnosis 38
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 37
Protein kinase a detection in human urine samples 36
The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo 35
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 34
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug 34
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine 34
Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab. 33
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma 33
ZOLEDRONIC ACID INCREASES THE EXPRESSION OF NDRG1 GENE IN HUMAN ANDROGEN-INDEPENDENT PROSTATE CANCER PC3 CELLS 32
Immunotherapy of colorectal cancer: New perspectives after a long path 30
Immune cell infiltration and inflammatory landscape in primary brain tumours 29
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions 28
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer 27
Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA. 27
Totale 5.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.014
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020219 0 0 0 0 0 0 98 38 36 19 21 7
2020/2021667 38 8 56 32 101 27 84 50 51 67 83 70
2021/2022688 24 11 11 12 206 11 15 22 30 89 50 207
2022/20231.710 155 49 29 193 149 163 3 106 750 23 55 35
2023/2024740 72 32 54 37 202 93 19 20 12 5 51 143
2024/2025761 17 46 8 99 287 301 3 0 0 0 0 0
Totale 5.792